Intended for healthcare professionals

Rapid response to:


Regulation of electronic cigarettes

BMJ 2014; 349 doi: (Published 05 September 2014) Cite this as: BMJ 2014;349:g5484

Rapid Response:

E-cigarettes are also known as e-vaping devices and are a recent development in tobacco harm reduction. Studies have revealed that there is tremendous growth in the e-cigarette market and millions of people currently using them. E-cigarettes have become the fashion statement among young tobacco users.

It has the potential to kill as inhaling nicotine could be dangerous. It is also very harmful for passive smokers. A major concern is that e-cigarettes could perpetuate nicotine addiction in smokers or lead to nicotine addiction among youth. The most common side effects from e-cigarette use are sore throat, dry cough, and headache due to inhalation of PG/VG and/or nicotine. E-cigarettes are the subject of a public health dispute because of safety issues. There are health risks to users, non-users and bystanders. Appropriate legislative and regulatory measures to prevent the use of e-cigarettes are necessary. It is premature, however, to conclude that e-cigarettes are safe to use, in part because no long-term studies have been conducted.

E-cigarettes are set to be banned in India soon. The decision to ban E-cigarettes was initiated by India. The Union health ministry has decided to ban these “nicotine inhalers” through proper legislation soon. E-cigarette smoking is declared illegal in Punjab, India’s first state to do so (health department’s Chief Secretary, Vini Mahajan in a Smoke-free workshop organised by Union of South East Asia). 18 districts of Punjab have already been declared no smoking districts.

Competing interests: No competing interests

21 November 2014
Dr.Rajiv Kumar
Associate Professor, Deptt. of Pharmacology
Dr.Jagjit Singh
Government Medical College & Hospital, Chandigarh 160030. INDIA
House No- 1156 B, Sector 32 B, Chandigarh , 160030. INDIA.